VA SB313 | 2022 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 11 2022 - 25% progression, died in chamber
Action: 2022-02-15 - Stricken from Senate calendar (38-Y 2-N)
Text: Latest bill text (Amended) [HTML]

Summary

Retail sale of cannabis products by certain pharmaceutical processors and industrial hemp processors; sunset. Allows certain pharmaceutical processors and industrial hemp processors to sell, under the oversight of the Board of Directors of the Virginia Cannabis Control Authority (the Board), cannabis products at retail to unregistered persons who are 21 years of age or older without the need for a written certification. The bill directs the Board to adopt and enforce regulations governing such sales that shall model certain Board of Pharmacy regulations and comply with other requirements set forth in the bill. The bill requires pharmaceutical processors and industrial hemp processors engaging in such sales to pay a $1 million fee and collect a 21 percent excise tax, both of which shall ultimately be allocated to the Virginia Cannabis Control Authority to be used to assist independent cannabis retailers located in designated rural and urban opportunity zones. The bill also requires such pharmaceutical processors and industrial hemp processors to submit and comply with a plan describing how the processor will educate consumers about responsible consumption of cannabis products and incubate independent cannabis retailers or support and educate persons that wish to participate in the cannabis market. The bill has a delayed effective date of January 1, 2023, and shall expire when pharmaceutical processors and industrial hemp processors engaging in the sale of cannabis products pursuant to the provisions of the bill are authorized by the Virginia Cannabis Control Authority to apply for and be granted licenses to cultivate, manufacture, wholesale, and sell at retail to consumers 21 years of age or older retail marijuana and retail marijuana products. Retail sale of cannabis products by certain pharmaceutical processors and industrial hemp processors; sunset. Allows certain pharmaceutical processors and industrial hemp processors to sell, under the oversight of the Board of Directors of the Virginia Cannabis Control Authority (the Board), cannabis products at retail to unregistered persons who are 21 years of age or older without the need for a written certification. The bill directs the Board to adopt and enforce regulations governing such sales that shall model certain Board of Pharmacy regulations and comply with other requirements set forth in the bill. The bill requires pharmaceutical processors and industrial hemp processors engaging in such sales to pay a $1 million fee and collect a 21 percent excise tax, both of which shall ultimately be allocated to the Virginia Cannabis Control Authority to be used to assist independent cannabis retailers located in designated rural and urban opportunity zones. The bill also requires such pharmaceutical processors and industrial hemp processors to submit and comply with a plan describing how the processor will educate consumers about responsible consumption of cannabis products and incubate independent cannabis retailers or support and educate persons that wish to participate in the cannabis market. The bill has a delayed effective date of January 1, 2023, and shall expire when pharmaceutical processors and industrial hemp processors engaging in the sale of cannabis products pursuant to the provisions of the bill are authorized by the Virginia Cannabis Control Authority to apply for and be granted licenses to cultivate, manufacture, wholesale, and sell at retail to consumers 21 years of age or older retail marijuana and retail marijuana products.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Cannabis products; retail sale by certain pharmaceutical processors & industrial hemp processors.

Sponsors


Roll Calls

2022-02-15 - Senate - Senate: Stricken from Senate calendar (38-Y 2-N) (Y: 38 N: 2 NV: 0 Abs: 0) [PASS]
2022-02-15 - Senate - Senate: Reconsideration of Passed by for the day agreed to (40-Y 0-N) (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2022-02-15 - Senate - Senate: Passed by for the day (21-Y 19-N) (Y: 21 N: 19 NV: 0 Abs: 0) [PASS]
2022-02-14 - Senate - Senate: Substitute by Senator Morrissey agreed to (21-Y 18-N) (Y: 21 N: 18 NV: 0 Abs: 1) [PASS]
2022-02-11 - Senate - Senate: Constitutional reading dispensed (40-Y 0-N) (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2022-02-10 - Senate - Senate: Reported from Finance and Appropriations (11-Y 3-N 2-A) (Y: 11 N: 3 NV: 2 Abs: 0) [PASS]
2022-02-04 - Senate - Senate: Reported from Rehabilitation and Social Services with substitute (8-Y 7-N) (Y: 8 N: 7 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2022-02-15SenateStricken from Senate calendar (38-Y 2-N)
2022-02-15SenateReconsideration of Passed by for the day agreed to (40-Y 0-N)
2022-02-15SenatePassed by for the day (21-Y 19-N)
2022-02-15SenateRead second time
2022-02-14SenatePassed by for the day
2022-02-14SenateAmendment by Senator Morrissey agreed to
2022-02-14SenateReading of amendment waived
2022-02-14SenateTitle replaced 22106562D-S2
2022-02-14SenateSubstitute by Senator Morrissey agreed to (21-Y 18-N)
2022-02-14SenateReading of substitute waived
2022-02-14SenateCommittee substitute rejected 22105965D-S1
2022-02-14SenateRead second time
2022-02-14SenateFloor substitute printed 22106563D-S3 (Ebbin)
2022-02-14SenateFloor substitute printed 22106562D-S2 (Morrissey)
2022-02-11SenateConstitutional reading dispensed (40-Y 0-N)
2022-02-10SenateReported from Finance and Appropriations (11-Y 3-N 2-A)
2022-02-04SenateIncorporates SB621 (Dunnavant)
2022-02-04SenateCommittee substitute printed 22105965D-S1
2022-02-04SenateRereferred to Finance and Appropriations
2022-02-04SenateReported from Rehabilitation and Social Services with substitute (8-Y 7-N)
2022-01-18SenateAssigned Rehab sub: Cannabis
2022-01-11SenateReferred to Committee on Rehabilitation and Social Services
2022-01-11SenatePrefiled and ordered printed; offered 01/12/22 22104291D

Subjects


Virginia State Sources

TypeSource
Summaryhttps://lis.virginia.gov/cgi-bin/legp604.exe?221+sum+SB313
Texthttps://lis.virginia.gov/cgi-bin/legp604.exe?221+ful+SB313+hil
Texthttps://lis.virginia.gov/cgi-bin/legp604.exe?221+ful+SB313S1+hil
Texthttps://lis.virginia.gov/cgi-bin/legp604.exe?221+ful+SB313S2+hil
Texthttps://lis.virginia.gov/cgi-bin/legp604.exe?221+ful+SB313S3+hil
Amendmenthttps://committees.lis.virginia.gov/pdfs/drafts/22105794D.pdf
Amendmenthttps://committees.lis.virginia.gov/pdfs/drafts/22105965D.pdf
Amendmenthttps://lis.virginia.gov/cgi-bin/legp604.exe?221+amd+SB313AS
Supplementhttps://lis.virginia.gov/cgi-bin/legp604.exe?221+oth+SB313FS1122+PDF
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?221+vot+S09V0038+SB0313
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?221+vot+S05V0200+SB0313
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?221+vot+SV0359SB0313+SB0313
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?221+vot+SV0411SB0313+SB0313
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?221+vot+SV0454SB0313+SB0313
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?221+vot+SV0474SB0313+SB0313
Roll Callhttps://lis.virginia.gov/cgi-bin/legp604.exe?221+vot+SV0475SB0313+SB0313

Bill Comments

feedback